ASBPW

Aspire Biopharma Warrant
ASBPW

35 hedge funds and large institutions have $2.63M invested in Aspire Biopharma Warrant in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.12M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11K
2
+$9.42K
3
+$562
4
FSI
Flow State Investments
Illinois
+$327

Top Sellers

1
-$6.42K
2
-$1.97K
3
-$1.24K
4
MP
Mangrove Partners
Connecticut
-$139
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3.13K
27
$3.13K
28
$3K
29
$2.34K
30
$2.3K
31
$2K
32
$1.04K
33
$1K
34
$523
35
$523
36
–
1
2